G-CSF Prophylaxis in High-Risk Female Patients with solid Tumors in clinical Practice: IMPACT SOLID Study

被引：0
|
作者：
Vavra, C. [1 ,2 ]
Singer, C. [3 ]
Staudigl, C. [3 ]
Hubalek, M. [4 ]
Unterrieder, K.
Jaeger, C. [5 ]
Sevelda, P. [1 ,2 ]
机构：
[1] Krankenhaus Hietzing Neurol Zentrum Rosenhugel, Gynakol Geburtshilfliche Abt, Vienna, Austria
[2] Karl Landsteiner Inst Gynakolog Onkol & Senol, Vienna, Austria
[3] Med Univ Wien, Univ Klin Frauenheilkunde, Vienna, Austria
[4] Med Univ Innsbruck, Univ Klin Frauenheilkunde, Klin Abt Gynakol & Geburtshilfe, Innsbruck, Austria
[5] Amgen GmbH, Vienna, Austria
来源：
GEBURTSHILFE UND FRAUENHEILKUNDE | 2012年 / 72卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] A probability/risk matrix of febrile neutropenia to select patients for G-CSF primary prophylaxis
    Ramchandani Vaswani, A.
    Faez, L.
    Selvi Miralles, M.
    Antonio-Rebollo, M.
    Font Puig, C.
    Espinosa Arranz, J.
    Biosca, M.
    Vicente Rubio, E.
    Jimenez Fonseca, P.
    Carmona-Bayonas, A.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S275 - S276
  • [22] Delayed Granulocyte Colony-Stimulating Factor (G-CSF) Administration after Chemotherapy Reduces Total G-CSF Doses without Affecting Neutrophil Recovery in a Randomized Clinical Study in Children with Solid Tumors
    Yankelevich, Maxim
    Hoogstra, David J.
    Abrams, Judith
    Chu, Roland
    Bhambhani, Kanta
    Taub, Jeffrey W.
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2020, 37 (08) : 665 - 675
  • [23] Improvement of quality of life by G-CSF prophylaxis in high risk patients with colorectal cancer surgery - Results of a randomized
    Bauhofer, A
    Lorenz, W
    Stinner, B
    SHOCK, 2004, 21 : 38 - 38
  • [24] Primary prophylaxis with G-CSF for patients with non-round cell soft tissue sarcomas: a systematic review for the Clinical Practice Guidelines for the Use of G-CSF 2022 of the Japan Society of Clinical Oncology
    Hirose, Takeshi
    Ito, Mamoru
    Tsuchihashi, Kenji
    Ozaki, Yukinori
    Nishio, Hiroshi
    Ichihara, Eiki
    Miura, Yuji
    Yano, Shingo
    Maruyama, Dai
    Yoshinami, Tetsuhiro
    Susumu, Nobuyuki
    Takekuma, Munetaka
    Motohashi, Takashi
    Baba, Eishi
    Ochi, Nobuaki
    Kubo, Toshio
    Uchino, Keita
    Kimura, Takahiro
    Kamiyama, Yutaro
    Nakao, Shinji
    Tamura, Shinobu
    Nishimoto, Hitomi
    Kato, Yasuhisa
    Sato, Atsushi
    Takano, Toshimi
    Endo, Makoto
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2024, : 1067 - 1073
  • [25] SINGLE-DOSE G-CSF AVOIDS CHEMOTHERAPY DELAY IN PATIENTS RECEIVING CONVENTIONAL CHEMOTHERAPY REGIMENS FOR SOLID TUMORS
    BAZARBASHI, MS
    RAJA, MA
    EZZAT, A
    WIERZBICKI, R
    ELWARITH, A
    KHALIFA, F
    BLOOD, 1994, 84 (10) : A587 - A587
  • [26] Reduced intensity conditioning regimen followed by glycosylated G-CSF mobilized PBSCT in patients with solid tumors and malignant lymphomas
    Castagna, L
    Bertuzzi, A
    Nozza, A
    Siracusano, L
    Balzarotti, M
    Magagnoli, M
    Sarina, B
    Timofeeva, I
    Sinnone, M
    Grimoldi, MG
    Farè, M
    Santoro, A
    BONE MARROW TRANSPLANTATION, 2002, 30 (04) : 207 - 214
  • [27] Effectiveness of G-CSF in chemotherapy for digestive system tumors: a systematic review of the Clinical Practice Guidelines for the Use of G-CSF 2022 delineated by the Japan Society of Clinical Oncology
    Ito, Mamoru
    Okumura, Yuta
    Nio, Kenta
    Baba, Eishi
    Ozaki, Yukinori
    Nishio, Hiroshi
    Ichihara, Eiki
    Miura, Yuji
    Endo, Makoto
    Yano, Shingo
    Maruyama, Dai
    Yoshinami, Tetsuhiro
    Susumu, Nobuyuki
    Takekuma, Munetaka
    Motohashi, Takashi
    Ochi, Nobuaki
    Kubo, Toshio
    Uchino, Keita
    Kimura, Takahiro
    Kamiyama, Yutaro
    Nakao, Shinji
    Tamura, Shinobu
    Nishimoto, Hitomi
    Kato, Yasuhisa
    Sato, Atsushi
    Takano, Toshimi
    Tsuchihashi, Kenji
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2024, 29 (06) : 689 - 699
  • [28] Randomized trial of sequential administration of G-CSF and GM-CSF vs. G-CSF alone following peripheral blood progenitor cell autograft in solid tumors
    Recchia, F
    Accorsi, P
    Bonfini, T
    De Filippis, S
    Grimaldi, M
    Corrao, G
    Rosselli, M
    Amiconi, G
    Iacone, A
    Rea, S
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2000, 20 (02): : 171 - 177
  • [29] Reduced intensity conditioning regimen followed by glycosylated G-CSF mobilized PBSCT in patients with solid tumors and malignant lymphomas
    L Castagna
    A Bertuzzi
    A Nozza
    L Siracusano
    M Balzarotti
    M Magagnoli
    B Sarina
    I Timofeeva
    M Sinnone
    MG Grimoldi
    M Farè
    A Santoro
    Bone Marrow Transplantation, 2002, 30 : 207 - 214
  • [30] Perioperative prophylaxis with granulocyte colony-stimulating factor (G-CSF) in high-risk colorectal cancer patients for an improved recovery:: A randomized, controlled trial
    Bauhofer, Artur
    Plaul, Ulrike
    Torossian, Alexander
    Koller, Michael
    Stinner, Benno
    Celik, Ilhan
    Sitter, Helmut
    Greger, Bernd
    Middeke, Martin
    Schein, Moshe
    Wyatt, Jeremy
    Nystrom, Per-Olof
    Hartung, Thomas
    Rothmund, Matthias
    Lorenz, Wilfried
    SURGERY, 2007, 141 (04) : 501 - 510
12345